Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
Abstract Immunotherapies targeting pathological tau have recently emerged as a promising approach for treatment of neurodegenerative disorders. We have previously showed that the mouse antibody DC8E8 discriminates between healthy and pathological tau, reduces tau pathology in murine tauopathy models...
Main Authors: | Monika Zilkova, Anna Nolle, Branislav Kovacech, Eva Kontsekova, Petronela Weisova, Peter Filipcik, Rostislav Skrabana, Michal Prcina, Tomas Hromadka, Ondrej Cehlar, Gabriela Paulikova Rolkova, Denisa Maderova, Michal Novak, Norbert Zilka, Jeroen J. M. Hoozemans |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40478-020-00948-z |
Similar Items
-
Differences Between Human and Murine Tau at the N-terminal End
by: Félix Hernández, et al.
Published: (2020-01-01) -
A nonhuman primate model with Alzheimer’s disease-like pathology induced by hippocampal overexpression of human tau
by: Zhouquan Jiang, et al.
Published: (2024-01-01) -
Reassessment of Neuronal Tau Distribution in Adult Human Brain and Implications for Tau Pathobiology
by: Giavanna Paterno, et al.
Published: (2022-06-01) -
Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
by: Ben Boyarko, et al.
Published: (2021-10-01) -
Intersection of pathological tau and microglia at the synapse
by: Thomas Vogels, et al.
Published: (2019-07-01)